HEADER TRANSFERASE/TRANSFERASE INHIBITOR 13-NOV-13 4NKS TITLE CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE TITLE 2 DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 458-765); COMPND 5 SYNONYM: FGFR-1, BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1, BFGFR, COMPND 6 BFGF-R-1, FMS-LIKE TYROSINE KINASE 2, FLT-2, N-SAM, PROTO-ONCOGENE C- COMPND 7 FGR; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, ATP BINDING, PHOSPHORYLATION, TRANS-MEMBRANE, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.A.NORMAN,T.KLEIN REVDAT 3 28-FEB-24 4NKS 1 REMARK SEQADV REVDAT 2 16-JUL-14 4NKS 1 JRNL REVDAT 1 18-DEC-13 4NKS 0 JRNL AUTH T.KLEIN,J.TUCKER,G.A.HOLDGATE,R.A.NORMAN,A.L.BREEZE JRNL TITL FGFR1 KINASE INHIBITORS: CLOSE REGIOISOMERS ADOPT DIVERGENT JRNL TITL 2 BINDING MODES AND DISPLAY DISTINCT BIOPHYSICAL SIGNATURES. JRNL REF ACS MED CHEM LETT V. 5 166 2014 JRNL REFN ISSN 1948-5875 JRNL PMID 24900792 JRNL DOI 10.1021/ML4004205 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 99.01 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 23909 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1286 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.57 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1732 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.52 REMARK 3 BIN R VALUE (WORKING SET) : 0.2580 REMARK 3 BIN FREE R VALUE SET COUNT : 98 REMARK 3 BIN FREE R VALUE : 0.3550 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4113 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 22 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.00000 REMARK 3 B22 (A**2) : 5.95000 REMARK 3 B33 (A**2) : -0.93000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.58000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.433 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.299 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.216 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 20.039 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.900 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4262 ; 0.013 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4015 ; 0.005 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5778 ; 1.460 ; 1.991 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9200 ; 0.814 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 526 ; 5.965 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 167 ;36.407 ;23.713 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 702 ;15.655 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;13.326 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 654 ; 0.077 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4713 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 905 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2134 ; 2.575 ; 3.814 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2133 ; 2.575 ; 3.813 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2647 ; 3.327 ; 5.701 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2648 ; 3.326 ; 5.702 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2128 ; 2.944 ; 3.949 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2127 ; 2.944 ; 3.948 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3131 ; 3.930 ; 5.857 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4707 ; 4.594 ;30.390 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4701 ; 4.595 ;30.364 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 465 A 762 REMARK 3 RESIDUE RANGE : A 801 A 801 REMARK 3 RESIDUE RANGE : A 901 A 913 REMARK 3 ORIGIN FOR THE GROUP (A): 80.4431 -2.3097 18.9745 REMARK 3 T TENSOR REMARK 3 T11: 0.0696 T22: 0.0409 REMARK 3 T33: 0.0604 T12: -0.0335 REMARK 3 T13: -0.0062 T23: 0.0360 REMARK 3 L TENSOR REMARK 3 L11: 1.6936 L22: 0.2923 REMARK 3 L33: 0.4648 L12: -0.3226 REMARK 3 L13: -0.2203 L23: -0.2310 REMARK 3 S TENSOR REMARK 3 S11: 0.0615 S12: 0.1256 S13: 0.1557 REMARK 3 S21: -0.0059 S22: -0.0578 S23: -0.0432 REMARK 3 S31: -0.0806 S32: 0.0574 S33: -0.0038 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 461 B 761 REMARK 3 RESIDUE RANGE : B 801 B 801 REMARK 3 RESIDUE RANGE : B 901 B 909 REMARK 3 ORIGIN FOR THE GROUP (A): 33.8444 1.8465 13.8298 REMARK 3 T TENSOR REMARK 3 T11: 0.0995 T22: 0.0631 REMARK 3 T33: 0.0513 T12: 0.0070 REMARK 3 T13: -0.0224 T23: -0.0193 REMARK 3 L TENSOR REMARK 3 L11: 2.4896 L22: 0.5456 REMARK 3 L33: 0.6296 L12: -0.7097 REMARK 3 L13: 0.3256 L23: 0.2316 REMARK 3 S TENSOR REMARK 3 S11: 0.2111 S12: 0.2757 S13: -0.1014 REMARK 3 S21: -0.0001 S22: -0.1712 S23: 0.0656 REMARK 3 S31: 0.0768 S32: 0.0103 S33: -0.0399 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4NKS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-DEC-13. REMARK 100 THE DEPOSITION ID IS D_1000083327. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23909 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 99.010 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.44200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16-20% PEG 8000, 100MM PCTP, 100-300MM REMARK 280 AMMONIUM SULFATE, 25% ETHYLENE GLYCOL, PH 6.75, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 104.02900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.45900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 104.02900 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.45900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 457 REMARK 465 ALA A 458 REMARK 465 GLY A 459 REMARK 465 VAL A 460 REMARK 465 SER A 461 REMARK 465 GLU A 462 REMARK 465 TYR A 463 REMARK 465 GLU A 464 REMARK 465 GLU A 486 REMARK 465 GLY A 487 REMARK 465 ALA A 488 REMARK 465 PHE A 489 REMARK 465 GLY A 490 REMARK 465 GLY A 499 REMARK 465 LEU A 500 REMARK 465 ASP A 501 REMARK 465 LYS A 502 REMARK 465 ASP A 503 REMARK 465 LYS A 504 REMARK 465 PRO A 505 REMARK 465 SER A 518 REMARK 465 GLY A 580 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 SER A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 PRO A 591 REMARK 465 GLU A 592 REMARK 465 GLU A 593 REMARK 465 ALA A 645 REMARK 465 ARG A 646 REMARK 465 ASP A 647 REMARK 465 ILE A 648 REMARK 465 HIS A 649 REMARK 465 HIS A 650 REMARK 465 ASN A 763 REMARK 465 GLN A 764 REMARK 465 GLU A 765 REMARK 465 GLY B 457 REMARK 465 ALA B 458 REMARK 465 GLY B 459 REMARK 465 VAL B 460 REMARK 465 PHE B 489 REMARK 465 ASP B 501 REMARK 465 LYS B 502 REMARK 465 ASP B 503 REMARK 465 LYS B 504 REMARK 465 PRO B 578 REMARK 465 PRO B 579 REMARK 465 GLY B 580 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 GLU B 592 REMARK 465 GLU B 593 REMARK 465 ARG B 646 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 ILE B 651 REMARK 465 THR B 657 REMARK 465 THR B 658 REMARK 465 ASN B 659 REMARK 465 SER B 762 REMARK 465 ASN B 763 REMARK 465 GLN B 764 REMARK 465 GLU B 765 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 465 CG CD1 CD2 REMARK 470 GLU A 467 CG CD OE1 OE2 REMARK 470 GLN A 491 CG CD OE1 NE2 REMARK 470 ARG A 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 517 CD CE NZ REMARK 470 ASP A 519 CG OD1 OD2 REMARK 470 GLU A 522 CG CD OE1 OE2 REMARK 470 LYS A 540 CD CE NZ REMARK 470 LYS A 542 CE NZ REMARK 470 GLN A 594 CG CD OE1 NE2 REMARK 470 ARG A 609 NE CZ NH1 NH2 REMARK 470 LYS A 655 CG CD CE NZ REMARK 470 LYS A 656 CD CE NZ REMARK 470 THR A 658 OG1 CG2 REMARK 470 ARG A 675 CD NE CZ NH1 NH2 REMARK 470 GLU A 707 CG CD OE1 OE2 REMARK 470 LYS A 711 CD CE NZ REMARK 470 ASN A 724 CG OD1 ND2 REMARK 470 MET A 731 CG SD CE REMARK 470 SER B 461 OG REMARK 470 GLU B 462 CG CD OE1 OE2 REMARK 470 GLU B 464 CG CD OE1 OE2 REMARK 470 GLU B 467 CG CD OE1 OE2 REMARK 470 ARG B 477 NE CZ NH1 NH2 REMARK 470 LYS B 482 CG CD CE NZ REMARK 470 GLU B 486 CG CD OE1 OE2 REMARK 470 ARG B 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 510 CD CE NZ REMARK 470 GLU B 522 CG CD OE1 OE2 REMARK 470 LYS B 523 CD CE NZ REMARK 470 LYS B 540 CG CD CE NZ REMARK 470 LYS B 542 CG CD CE NZ REMARK 470 GLN B 594 CG CD OE1 NE2 REMARK 470 LYS B 598 CG CD CE NZ REMARK 470 LYS B 618 CG CD CE NZ REMARK 470 GLU B 633 CD OE1 OE2 REMARK 470 LYS B 655 CD CE NZ REMARK 470 LYS B 656 CG CD CE NZ REMARK 470 ARG B 675 CD NE CZ NH1 NH2 REMARK 470 GLU B 707 CG CD OE1 OE2 REMARK 470 LYS B 714 CG CD CE NZ REMARK 470 LYS B 721 CD CE NZ REMARK 470 ASN B 727 CG OD1 ND2 REMARK 470 GLU B 728 CG CD OE1 OE2 REMARK 470 MET B 731 CG SD CE REMARK 470 LYS B 748 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 622 -17.00 76.92 REMARK 500 ASP A 623 58.96 -145.25 REMARK 500 ASN A 724 57.16 -90.25 REMARK 500 ALA B 575 0.90 -60.64 REMARK 500 ARG B 622 -22.60 81.34 REMARK 500 LYS B 665 1.58 -64.80 REMARK 500 PHE B 673 -79.63 -84.17 REMARK 500 ASP B 674 2.05 -66.14 REMARK 500 ASN B 724 64.86 72.81 REMARK 500 CYS B 725 112.33 -179.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2M2 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2M2 B 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4F63 RELATED DB: PDB REMARK 900 RELATED ID: 4F64 RELATED DB: PDB REMARK 900 RELATED ID: 4F65 RELATED DB: PDB REMARK 900 RELATED ID: 4NK9 RELATED DB: PDB REMARK 900 RELATED ID: 4NKA RELATED DB: PDB DBREF 4NKS A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 4NKS B 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 4NKS GLY A 457 UNP P11362 EXPRESSION TAG SEQADV 4NKS ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4NKS SER A 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQADV 4NKS GLY B 457 UNP P11362 EXPRESSION TAG SEQADV 4NKS ALA B 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4NKS SER B 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQRES 1 A 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 A 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 A 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 A 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 A 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 A 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 A 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 A 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 A 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 A 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 A 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 A 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 A 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 A 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 A 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 A 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 A 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 A 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 A 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 A 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 A 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 A 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 A 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 A 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 B 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 B 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 B 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 B 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 B 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 B 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 B 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 B 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 B 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 B 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 B 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 B 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 B 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 B 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 B 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 B 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 B 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 B 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 B 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 B 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 B 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 B 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 B 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET 2M2 A 801 28 HET 2M2 B 801 28 HETNAM 2M2 N~2~-[(3-METHYL-1,2-OXAZOL-5-YL)METHYL]-N~4~-[5-(2- HETNAM 2 2M2 PHENYLETHYL)-1H-PYRAZOL-3-YL]PYRIMIDINE-2,4-DIAMINE FORMUL 3 2M2 2(C20 H21 N7 O) FORMUL 5 HOH *22(H2 O) HELIX 1 1 PRO A 474 ASP A 476 5 3 HELIX 2 2 THR A 521 GLY A 539 1 19 HELIX 3 3 ASN A 568 ARG A 576 1 9 HELIX 4 4 SER A 596 LYS A 617 1 22 HELIX 5 5 ALA A 625 ARG A 627 5 3 HELIX 6 6 LEU A 662 MET A 667 5 6 HELIX 7 7 ALA A 668 ARG A 675 1 8 HELIX 8 8 THR A 678 THR A 695 1 18 HELIX 9 9 PRO A 705 GLU A 715 1 11 HELIX 10 10 THR A 726 TRP A 737 1 12 HELIX 11 11 VAL A 740 ARG A 744 5 5 HELIX 12 12 THR A 746 THR A 761 1 16 HELIX 13 13 PRO B 474 ASP B 476 5 3 HELIX 14 14 THR B 521 GLY B 539 1 19 HELIX 15 15 ASN B 568 ALA B 575 1 8 HELIX 16 16 SER B 596 LYS B 617 1 22 HELIX 17 17 ALA B 625 ARG B 627 5 3 HELIX 18 18 LEU B 662 MET B 667 5 6 HELIX 19 19 ALA B 668 PHE B 673 1 6 HELIX 20 20 THR B 678 THR B 695 1 18 HELIX 21 21 PRO B 705 GLU B 715 1 11 HELIX 22 22 THR B 726 TRP B 737 1 12 HELIX 23 23 VAL B 740 ARG B 744 5 5 HELIX 24 24 THR B 746 LEU B 760 1 15 SHEET 1 A 5 LEU A 478 PRO A 483 0 SHEET 2 A 5 VAL A 492 ALA A 497 -1 O LEU A 494 N LYS A 482 SHEET 3 A 5 THR A 509 LYS A 514 -1 O THR A 509 N ALA A 497 SHEET 4 A 5 TYR A 558 GLU A 562 -1 O VAL A 561 N ALA A 512 SHEET 5 A 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 B 2 VAL A 629 VAL A 631 0 SHEET 2 B 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 C 5 LEU B 478 GLU B 486 0 SHEET 2 C 5 GLN B 491 ILE B 498 -1 O LEU B 494 N LYS B 482 SHEET 3 C 5 VAL B 508 MET B 515 -1 O VAL B 511 N ALA B 495 SHEET 4 C 5 TYR B 558 GLU B 562 -1 O VAL B 561 N ALA B 512 SHEET 5 C 5 LEU B 547 CYS B 551 -1 N CYS B 551 O TYR B 558 SHEET 1 D 2 VAL B 629 VAL B 631 0 SHEET 2 D 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 SITE 1 AC1 8 LEU A 484 LYS A 514 GLU A 531 VAL A 561 SITE 2 AC1 8 GLU A 562 TYR A 563 ALA A 564 LEU A 630 SITE 1 AC2 9 LEU B 484 ALA B 512 LYS B 514 GLU B 531 SITE 2 AC2 9 VAL B 561 GLU B 562 TYR B 563 ALA B 564 SITE 3 AC2 9 LEU B 630 CRYST1 208.058 56.918 66.242 90.00 107.73 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004806 0.000000 0.001537 0.00000 SCALE2 0.000000 0.017569 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015849 0.00000